These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120 [TBL] [Abstract][Full Text] [Related]
7. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin. Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciprofloxacin in elderly patients. Kees F; Naber KG; Meyer GP; Grobecker H Arzneimittelforschung; 1989 Apr; 39(4):523-7. PubMed ID: 2751742 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa. Honeybourne D; Andrews JM; Ashby JP; Lodwick R; Wise R Thorax; 1988 Sep; 43(9):715-9. PubMed ID: 3194878 [TBL] [Abstract][Full Text] [Related]
10. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin. Rohwedder R; Bergan T; Caruso E; Thorsteinsson SB; Della Torre H; Scholl H Chemotherapy; 1991; 37(4):229-38. PubMed ID: 1790720 [TBL] [Abstract][Full Text] [Related]
11. Penetration of ciprofloxacin in bronchial secretions after intravenous administration. Berré J; Thys JP; Husson M; Gangji D; Klastersky J J Antimicrob Chemother; 1988 Oct; 22(4):499-504. PubMed ID: 3204076 [TBL] [Abstract][Full Text] [Related]
12. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability. Bressolle F; de la Coussaye JE; Ayoub R; Fabre D; Gomeni R; Saissi G; Eledjam JJ; Galtier M Antimicrob Agents Chemother; 1992 Jul; 36(7):1404-11. PubMed ID: 1510435 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. Papich MG; Van Camp SD; Cole JA; Whitacre MD J Vet Pharmacol Ther; 2002 Oct; 25(5):343-50. PubMed ID: 12423224 [TBL] [Abstract][Full Text] [Related]
14. [Diffusion of ciprofloxacin into bronchial secretions in mechanically ventilated patients]. Saux P; Martin C; Portet C; Bruguerolle B; Papazian L; Mallet MN; Gouin F Pathol Biol (Paris); 1991 May; 39(5):515-9. PubMed ID: 1881686 [TBL] [Abstract][Full Text] [Related]
15. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po. Catchpole C; Andrews JM; Woodcock J; Wise R J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Kinzig M; Sörgel F; Brismar B; Nord CE Antimicrob Agents Chemother; 1992 Sep; 36(9):1997-2004. PubMed ID: 1329637 [TBL] [Abstract][Full Text] [Related]
18. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Brunner M; Stabeta H; Möller JG; Schrolnberger C; Erovic B; Hollenstein U; Zeitlinger M; Eichler HG; Müller M Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334 [TBL] [Abstract][Full Text] [Related]
20. Penetration of ciprofloxacin into bronchial secretions. Bergogne-Bérézin E; Berthelot G; Even P; Stern M; Reynaud P Eur J Clin Microbiol; 1986 Apr; 5(2):197-200. PubMed ID: 2941280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]